Scientists from Denmark optimistic they are getting close to finding drugs to treat human immunodeficiency virus (HIV).
Research conducted by a team from Aarhus University Hospital has reached the human clinical trials using new strategies that have proven effective in laboratory tests.
Though a few days before the U.S. government reported that research to develop an AIDS vaccine clinical trial discontinued due to disappointing show.
The team of scientists from Denmark using therapeutic viruses rid of some sort of tendon cells are made of DNA, which with the help of the body's immune system and a little help from the vaccine, could be destroyed.
Although therapy has proven effective when tested using human skin cells in the lab, efficacy or success of the human body has not been proven.
"The challenge is to make the patient's immune system to recognize and destroy the virus. This depends on the strength and sensitivity of individual immune systems," said Dr.Ole Sogaard, senior researcher.
Human studies that will involve 15 patients with funding from the Danish Research Council of 2.1 million dollars. A similar study conducted by a team of British scientists from five universities. Both research that aims to cure people who are already infected with the virus, not prevent HIV or AIDS.
Dr.Anthony Fauci, head of the U.S. National Institute of Allergy and Infectious Diseases, said the failure of the development of AIDS vaccine research is "disappointing, but at least he is no important information is obtained.
The study involved 2,504 volunteers in 19 cities in the United States since 2009. Prior to this, many studies have been done for a new AIDS vaccine, but all have failed.
No comments:
Post a Comment